University of Minnesota

Rifaximin was PBS-listed on 1 December 2013 for prevention of hepatic encephalopathy (HE) in combination with lactulose, if tolerated, in a patient who has had prior episodes of HE; after consideration at the July 2012, November 2012, March 2013 and April 2013 PBAC meetings. ................
................